| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyaluronic Acid | 91 | 2019 | 206 | 9.220 |
Why?
|
| Basigin | 43 | 2019 | 53 | 5.100 |
Why?
|
| Hyaluronan Receptors | 38 | 2019 | 142 | 3.820 |
Why?
|
| Antigens, CD | 21 | 2009 | 230 | 2.090 |
Why?
|
| Drug Resistance, Neoplasm | 14 | 2014 | 332 | 1.830 |
Why?
|
| Antigens, Neoplasm | 19 | 2004 | 132 | 1.550 |
Why?
|
| Neoplasms | 13 | 2019 | 1667 | 1.280 |
Why?
|
| Membrane Glycoproteins | 20 | 2004 | 370 | 1.260 |
Why?
|
| Neoplasm Invasiveness | 18 | 2014 | 369 | 1.070 |
Why?
|
| Oligosaccharides | 8 | 2009 | 26 | 1.060 |
Why?
|
| Herpesvirus 8, Human | 9 | 2016 | 24 | 0.990 |
Why?
|
| Cell Membrane | 17 | 2019 | 525 | 0.980 |
Why?
|
| Extremities | 16 | 2009 | 49 | 0.960 |
Why?
|
| Neoplasm Proteins | 4 | 2014 | 307 | 0.900 |
Why?
|
| Carrier Proteins | 12 | 2002 | 597 | 0.880 |
Why?
|
| Animals | 105 | 2016 | 20881 | 0.840 |
Why?
|
| Proteoglycans | 8 | 2014 | 103 | 0.830 |
Why?
|
| Cell Communication | 7 | 2015 | 116 | 0.820 |
Why?
|
| Collagenases | 4 | 2015 | 34 | 0.780 |
Why?
|
| Neoplastic Stem Cells | 3 | 2019 | 84 | 0.780 |
Why?
|
| Mesoderm | 13 | 2013 | 231 | 0.780 |
Why?
|
| Cell Transformation, Viral | 16 | 2016 | 26 | 0.730 |
Why?
|
| Glioma | 6 | 2008 | 140 | 0.720 |
Why?
|
| Sarcoma, Kaposi | 6 | 2016 | 25 | 0.710 |
Why?
|
| Cell Line, Tumor | 16 | 2019 | 1851 | 0.680 |
Why?
|
| Vesicular Transport Proteins | 3 | 2014 | 87 | 0.630 |
Why?
|
| Fibroblasts | 19 | 2019 | 902 | 0.620 |
Why?
|
| Epithelial Cells | 7 | 2012 | 431 | 0.620 |
Why?
|
| Signal Transduction | 16 | 2014 | 2689 | 0.590 |
Why?
|
| Breast Neoplasms | 10 | 2013 | 1536 | 0.570 |
Why?
|
| Matrix Metalloproteinases | 7 | 2006 | 223 | 0.560 |
Why?
|
| Chick Embryo | 35 | 2013 | 379 | 0.560 |
Why?
|
| Tumor Cells, Cultured | 21 | 2011 | 852 | 0.560 |
Why?
|
| Cartilage | 17 | 2007 | 51 | 0.550 |
Why?
|
| Mice | 38 | 2016 | 8474 | 0.550 |
Why?
|
| Receptor, ErbB-2 | 4 | 2008 | 129 | 0.550 |
Why?
|
| Matrix Metalloproteinase 2 | 10 | 2019 | 145 | 0.550 |
Why?
|
| Neovascularization, Pathologic | 3 | 2014 | 183 | 0.520 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2011 | 223 | 0.510 |
Why?
|
| Cell Adhesion | 11 | 2014 | 324 | 0.500 |
Why?
|
| Membrane Microdomains | 4 | 2019 | 32 | 0.490 |
Why?
|
| ErbB Receptors | 2 | 2013 | 239 | 0.490 |
Why?
|
| Glucuronosyltransferase | 9 | 2015 | 38 | 0.480 |
Why?
|
| Hyaluronoglucosaminidase | 25 | 2004 | 43 | 0.480 |
Why?
|
| Humans | 77 | 2019 | 68618 | 0.470 |
Why?
|
| Monocarboxylic Acid Transporters | 3 | 2014 | 15 | 0.470 |
Why?
|
| Carcinoma | 5 | 2006 | 215 | 0.460 |
Why?
|
| Cell Survival | 8 | 2014 | 901 | 0.460 |
Why?
|
| Multiprotein Complexes | 1 | 2013 | 56 | 0.440 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 247 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2014 | 756 | 0.430 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 11 | 0.430 |
Why?
|
| Multiple Myeloma | 1 | 2014 | 92 | 0.430 |
Why?
|
| Spinal Cord Neoplasms | 3 | 2008 | 24 | 0.410 |
Why?
|
| Morphogenesis | 11 | 2005 | 159 | 0.410 |
Why?
|
| Cell Surface Extensions | 1 | 2012 | 5 | 0.410 |
Why?
|
| Avian Proteins | 5 | 2007 | 23 | 0.410 |
Why?
|
| Endothelium, Vascular | 6 | 2016 | 371 | 0.400 |
Why?
|
| Extracellular Matrix | 12 | 2009 | 493 | 0.390 |
Why?
|
| Membrane Proteins | 5 | 2003 | 617 | 0.380 |
Why?
|
| Apoptosis | 10 | 2016 | 1641 | 0.380 |
Why?
|
| Cells, Cultured | 29 | 2016 | 2673 | 0.380 |
Why?
|
| Ectoderm | 4 | 2007 | 8 | 0.370 |
Why?
|
| Base Sequence | 11 | 2012 | 1015 | 0.370 |
Why?
|
| Molecular Sequence Data | 15 | 2011 | 1447 | 0.370 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2008 | 100 | 0.370 |
Why?
|
| Glycosaminoglycans | 15 | 1995 | 88 | 0.340 |
Why?
|
| Antigens, Surface | 4 | 2002 | 71 | 0.330 |
Why?
|
| Astrocytoma | 2 | 2008 | 30 | 0.330 |
Why?
|
| Antineoplastic Agents | 5 | 2011 | 1070 | 0.330 |
Why?
|
| Lactates | 1 | 2009 | 29 | 0.330 |
Why?
|
| Blood Proteins | 4 | 2002 | 94 | 0.330 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 33 | 0.320 |
Why?
|
| RNA, Messenger | 15 | 2016 | 1664 | 0.320 |
Why?
|
| Brain Stem Neoplasms | 1 | 2008 | 6 | 0.320 |
Why?
|
| Receptors, Cell Surface | 6 | 2001 | 248 | 0.310 |
Why?
|
| Cell Line | 17 | 2012 | 1752 | 0.310 |
Why?
|
| Cell Movement | 13 | 2013 | 630 | 0.310 |
Why?
|
| Mammary Neoplasms, Experimental | 3 | 2000 | 114 | 0.310 |
Why?
|
| Epithelium | 3 | 2005 | 172 | 0.290 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2007 | 144 | 0.290 |
Why?
|
| Gene Expression Regulation | 6 | 2012 | 1293 | 0.280 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 434 | 0.280 |
Why?
|
| Protein Binding | 8 | 2014 | 1027 | 0.280 |
Why?
|
| Drug Resistance, Multiple | 4 | 2008 | 56 | 0.280 |
Why?
|
| Hyaluronan Synthases | 8 | 2015 | 21 | 0.280 |
Why?
|
| Drosophila Proteins | 2 | 1998 | 44 | 0.270 |
Why?
|
| Transfection | 9 | 2005 | 782 | 0.270 |
Why?
|
| Cell Division | 7 | 2004 | 541 | 0.270 |
Why?
|
| Molecular Chaperones | 2 | 1998 | 81 | 0.270 |
Why?
|
| Transferases | 2 | 2000 | 14 | 0.270 |
Why?
|
| Glycosyltransferases | 2 | 2000 | 13 | 0.260 |
Why?
|
| Blotting, Western | 12 | 2016 | 954 | 0.260 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2013 | 44 | 0.260 |
Why?
|
| Xenopus Proteins | 2 | 2000 | 31 | 0.260 |
Why?
|
| Up-Regulation | 8 | 2015 | 682 | 0.260 |
Why?
|
| Cell Proliferation | 8 | 2016 | 1174 | 0.260 |
Why?
|
| Genes, MDR | 1 | 2005 | 9 | 0.250 |
Why?
|
| Cell Cycle Proteins | 2 | 1998 | 230 | 0.240 |
Why?
|
| Receptors, Lymphocyte Homing | 2 | 1995 | 5 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 411 | 0.230 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2012 | 235 | 0.230 |
Why?
|
| Cloning, Molecular | 5 | 2002 | 357 | 0.230 |
Why?
|
| Werner Syndrome | 1 | 2003 | 1 | 0.220 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 4 | 2006 | 36 | 0.220 |
Why?
|
| Amino Acid Sequence | 10 | 2011 | 1083 | 0.220 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 7 | 0.220 |
Why?
|
| Simian virus 40 | 7 | 1987 | 24 | 0.220 |
Why?
|
| Ovarian Neoplasms | 2 | 2013 | 267 | 0.220 |
Why?
|
| Lectins, C-Type | 4 | 2006 | 39 | 0.210 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2014 | 135 | 0.210 |
Why?
|
| Collagen | 12 | 2003 | 636 | 0.210 |
Why?
|
| Matrix Metalloproteinase 1 | 4 | 2006 | 74 | 0.210 |
Why?
|
| Disease Progression | 4 | 2014 | 1038 | 0.210 |
Why?
|
| Neoplasms, Experimental | 2 | 2002 | 118 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2009 | 328 | 0.200 |
Why?
|
| Flow Cytometry | 6 | 2012 | 489 | 0.200 |
Why?
|
| Glycoproteins | 3 | 2003 | 238 | 0.200 |
Why?
|
| Phenotype | 5 | 2014 | 947 | 0.190 |
Why?
|
| Host-Pathogen Interactions | 2 | 2012 | 69 | 0.190 |
Why?
|
| Vascular Diseases | 1 | 2001 | 94 | 0.190 |
Why?
|
| Female | 22 | 2015 | 38074 | 0.190 |
Why?
|
| Antibodies, Monoclonal | 7 | 2001 | 511 | 0.190 |
Why?
|
| Lymphoma, Primary Effusion | 2 | 2011 | 7 | 0.190 |
Why?
|
| Skin | 7 | 2011 | 451 | 0.180 |
Why?
|
| Doxorubicin | 3 | 2009 | 231 | 0.180 |
Why?
|
| Antigens, Viral | 4 | 2016 | 35 | 0.180 |
Why?
|
| Ascites | 1 | 2000 | 38 | 0.180 |
Why?
|
| Biotin | 2 | 2001 | 28 | 0.180 |
Why?
|
| Colonic Neoplasms | 4 | 2008 | 299 | 0.170 |
Why?
|
| 5'-Nucleotidase | 1 | 2019 | 13 | 0.170 |
Why?
|
| Brain Neoplasms | 4 | 2008 | 371 | 0.170 |
Why?
|
| Peptide Fragments | 3 | 2011 | 483 | 0.170 |
Why?
|
| Progeria | 2 | 2011 | 6 | 0.170 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2016 | 45 | 0.160 |
Why?
|
| Kinetics | 11 | 2005 | 1047 | 0.160 |
Why?
|
| Rats | 12 | 2008 | 5300 | 0.160 |
Why?
|
| Chondroitin Sulfates | 8 | 1995 | 44 | 0.160 |
Why?
|
| Nuclear Proteins | 4 | 2016 | 271 | 0.160 |
Why?
|
| Lung Neoplasms | 8 | 2011 | 1173 | 0.160 |
Why?
|
| Fibroblast Growth Factor 2 | 3 | 1995 | 48 | 0.160 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 337 | 0.160 |
Why?
|
| Coculture Techniques | 5 | 2019 | 147 | 0.150 |
Why?
|
| DNA, Complementary | 6 | 2002 | 251 | 0.150 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2011 | 22 | 0.150 |
Why?
|
| Versicans | 3 | 2013 | 44 | 0.150 |
Why?
|
| Biomarkers, Tumor | 7 | 2008 | 508 | 0.150 |
Why?
|
| ADAM Proteins | 2 | 2016 | 53 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2005 | 1200 | 0.140 |
Why?
|
| Joints | 2 | 2009 | 30 | 0.140 |
Why?
|
| Polysaccharides | 3 | 2005 | 176 | 0.140 |
Why?
|
| Ear | 1 | 1997 | 12 | 0.140 |
Why?
|
| Tooth | 1 | 1997 | 24 | 0.140 |
Why?
|
| Nose | 1 | 1997 | 36 | 0.140 |
Why?
|
| Carcinogenesis | 2 | 2016 | 124 | 0.140 |
Why?
|
| Neoplasm Metastasis | 3 | 2004 | 306 | 0.140 |
Why?
|
| Cell Differentiation | 11 | 2013 | 1034 | 0.140 |
Why?
|
| Hair Follicle | 1 | 1997 | 37 | 0.140 |
Why?
|
| Mesentery | 1 | 1996 | 17 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2011 | 331 | 0.140 |
Why?
|
| Brain | 6 | 2000 | 2176 | 0.130 |
Why?
|
| beta Catenin | 3 | 2008 | 73 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 1996 | 93 | 0.130 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 217 | 0.130 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 40 | 0.130 |
Why?
|
| Metalloproteases | 2 | 2006 | 9 | 0.130 |
Why?
|
| Stromal Cells | 3 | 2014 | 113 | 0.130 |
Why?
|
| Bacteriophage M13 | 1 | 1995 | 12 | 0.130 |
Why?
|
| Real-Time Polymerase Chain Reaction | 5 | 2016 | 209 | 0.130 |
Why?
|
| Molecular Weight | 7 | 2000 | 358 | 0.130 |
Why?
|
| Sequence Deletion | 1 | 1995 | 89 | 0.130 |
Why?
|
| Epitopes | 1 | 1995 | 146 | 0.120 |
Why?
|
| Proteins | 3 | 1995 | 474 | 0.120 |
Why?
|
| Neuroglia | 1 | 1995 | 136 | 0.120 |
Why?
|
| Mouth Neoplasms | 2 | 2011 | 206 | 0.120 |
Why?
|
| Metalloendopeptidases | 3 | 2000 | 67 | 0.120 |
Why?
|
| Bone Development | 3 | 2009 | 37 | 0.120 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2015 | 123 | 0.120 |
Why?
|
| Activins | 1 | 2014 | 4 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2011 | 507 | 0.120 |
Why?
|
| Herpesviridae | 1 | 2014 | 11 | 0.120 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 76 | 0.110 |
Why?
|
| Endocardial Cushions | 1 | 2013 | 20 | 0.110 |
Why?
|
| Twist-Related Protein 1 | 1 | 2013 | 13 | 0.110 |
Why?
|
| Cytoskeletal Proteins | 2 | 2005 | 108 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 57 | 0.110 |
Why?
|
| Mice, SCID | 1 | 2014 | 238 | 0.110 |
Why?
|
| Dogs | 2 | 2005 | 490 | 0.110 |
Why?
|
| Hypoxia | 1 | 2014 | 169 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 196 | 0.110 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2012 | 8 | 0.110 |
Why?
|
| Avian Sarcoma Viruses | 4 | 1981 | 20 | 0.110 |
Why?
|
| Embryonic and Fetal Development | 2 | 2004 | 74 | 0.110 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2012 | 22 | 0.110 |
Why?
|
| Trans-Activators | 2 | 2005 | 237 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2013 | 147 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2012 | 45 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2003 | 295 | 0.110 |
Why?
|
| Blood Vessels | 1 | 1993 | 102 | 0.100 |
Why?
|
| Muscles | 2 | 1985 | 158 | 0.100 |
Why?
|
| Growth Substances | 2 | 1990 | 77 | 0.100 |
Why?
|
| DNA Primers | 3 | 2011 | 302 | 0.100 |
Why?
|
| RNA Interference | 4 | 2016 | 266 | 0.100 |
Why?
|
| Solubility | 4 | 2000 | 134 | 0.100 |
Why?
|
| Breast | 2 | 2012 | 137 | 0.100 |
Why?
|
| Receptors, Drug | 3 | 1981 | 31 | 0.100 |
Why?
|
| Heart | 2 | 2007 | 850 | 0.100 |
Why?
|
| Cyclophilin A | 2 | 2002 | 2 | 0.100 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 213 | 0.100 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2012 | 44 | 0.100 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 499 | 0.100 |
Why?
|
| Disaccharides | 1 | 2011 | 9 | 0.100 |
Why?
|
| Mouth | 1 | 2011 | 64 | 0.100 |
Why?
|
| NM23 Nucleoside Diphosphate Kinases | 1 | 2011 | 2 | 0.100 |
Why?
|
| Adenocarcinoma | 3 | 2011 | 475 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2008 | 120 | 0.090 |
Why?
|
| Gelatinases | 2 | 2003 | 12 | 0.090 |
Why?
|
| Sarcoma | 2 | 2011 | 70 | 0.090 |
Why?
|
| Recombinant Proteins | 5 | 2001 | 742 | 0.090 |
Why?
|
| Cricetinae | 5 | 2002 | 262 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 219 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2016 | 710 | 0.090 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 189 | 0.090 |
Why?
|
| Immunohistochemistry | 5 | 2019 | 1174 | 0.090 |
Why?
|
| Chondrosarcoma | 1 | 1989 | 7 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2016 | 304 | 0.090 |
Why?
|
| Transcription, Genetic | 4 | 2006 | 562 | 0.090 |
Why?
|
| Time Factors | 10 | 2006 | 4655 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2011 | 322 | 0.090 |
Why?
|
| Chondrocytes | 1 | 2009 | 27 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 284 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 132 | 0.080 |
Why?
|
| Models, Biological | 3 | 2019 | 981 | 0.080 |
Why?
|
| Exons | 3 | 1998 | 122 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2009 | 137 | 0.080 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 8 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2009 | 260 | 0.080 |
Why?
|
| Enzyme Induction | 6 | 2011 | 119 | 0.080 |
Why?
|
| Protein Biosynthesis | 3 | 1995 | 181 | 0.080 |
Why?
|
| Biological Transport | 1 | 2009 | 210 | 0.080 |
Why?
|
| Wings, Animal | 2 | 2007 | 6 | 0.080 |
Why?
|
| CHO Cells | 4 | 2002 | 161 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 1988 | 51 | 0.080 |
Why?
|
| Culture Media, Serum-Free | 3 | 2002 | 35 | 0.080 |
Why?
|
| Myocardium | 3 | 2007 | 1204 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2009 | 1692 | 0.080 |
Why?
|
| Cornea | 4 | 1982 | 76 | 0.070 |
Why?
|
| Enzyme Activation | 5 | 2011 | 791 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 447 | 0.070 |
Why?
|
| Cattle | 4 | 2001 | 475 | 0.070 |
Why?
|
| Synovial Membrane | 1 | 1987 | 23 | 0.070 |
Why?
|
| Intestines | 1 | 2008 | 114 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 160 | 0.070 |
Why?
|
| Culture Media, Conditioned | 3 | 2013 | 78 | 0.070 |
Why?
|
| Epithelioid Cells | 1 | 2007 | 3 | 0.070 |
Why?
|
| Receptors, Prostaglandin E | 1 | 2006 | 8 | 0.070 |
Why?
|
| Intestinal Mucosa | 1 | 2008 | 219 | 0.070 |
Why?
|
| Ductus Arteriosus | 1 | 2006 | 13 | 0.070 |
Why?
|
| Stem Cells | 1 | 2008 | 248 | 0.070 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2007 | 28 | 0.070 |
Why?
|
| Chondroitin | 7 | 1977 | 13 | 0.070 |
Why?
|
| Inflammation | 2 | 2004 | 1030 | 0.070 |
Why?
|
| Glycopeptides | 1 | 2006 | 15 | 0.070 |
Why?
|
| Esters | 1 | 2006 | 22 | 0.070 |
Why?
|
| Glycosylation | 2 | 2011 | 185 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1998 | 231 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 1745 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2006 | 381 | 0.070 |
Why?
|
| Endometrium | 1 | 2006 | 31 | 0.070 |
Why?
|
| Sulfhydryl Compounds | 1 | 2006 | 73 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 492 | 0.070 |
Why?
|
| Connective Tissue | 3 | 2004 | 61 | 0.060 |
Why?
|
| Brevican | 1 | 2005 | 2 | 0.060 |
Why?
|
| Aging | 1 | 2011 | 911 | 0.060 |
Why?
|
| Regeneration | 3 | 1977 | 105 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2003 | 261 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2005 | 38 | 0.060 |
Why?
|
| Monocytes | 1 | 2006 | 210 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 250 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2008 | 2550 | 0.060 |
Why?
|
| Lymphoma, T-Cell | 1 | 2004 | 19 | 0.060 |
Why?
|
| Down-Regulation | 3 | 2012 | 447 | 0.060 |
Why?
|
| Electrophoresis | 2 | 2003 | 69 | 0.060 |
Why?
|
| Keratins | 1 | 2003 | 48 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2003 | 88 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 2 | 2005 | 290 | 0.060 |
Why?
|
| Laminin | 1 | 2003 | 62 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 73 | 0.060 |
Why?
|
| Fibrosarcoma | 3 | 1991 | 21 | 0.060 |
Why?
|
| Cytoskeleton | 1 | 2003 | 84 | 0.050 |
Why?
|
| Aggrecans | 3 | 2009 | 13 | 0.050 |
Why?
|
| Immunoblotting | 1 | 2003 | 254 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2003 | 63 | 0.050 |
Why?
|
| Forecasting | 1 | 2004 | 277 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 2 | 1995 | 384 | 0.050 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2002 | 48 | 0.050 |
Why?
|
| bcl-Associated Death Protein | 1 | 2002 | 19 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2003 | 304 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2002 | 22 | 0.050 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2002 | 20 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2003 | 99 | 0.050 |
Why?
|
| Tumor Virus Infections | 1 | 1982 | 32 | 0.050 |
Why?
|
| Creatinine | 1 | 2003 | 243 | 0.050 |
Why?
|
| Extracellular Space | 4 | 1991 | 121 | 0.050 |
Why?
|
| Wound Healing | 1 | 2004 | 260 | 0.050 |
Why?
|
| Child | 3 | 2008 | 6405 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 453 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2002 | 94 | 0.050 |
Why?
|
| Caspases | 1 | 2002 | 194 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2008 | 2083 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 498 | 0.050 |
Why?
|
| Adult | 7 | 2015 | 21403 | 0.050 |
Why?
|
| In Vitro Techniques | 4 | 2001 | 765 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 233 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2002 | 108 | 0.050 |
Why?
|
| Fibronectins | 1 | 1982 | 130 | 0.050 |
Why?
|
| Introns | 2 | 1998 | 68 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2001 | 24 | 0.050 |
Why?
|
| Eye | 1 | 1982 | 89 | 0.050 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2002 | 194 | 0.050 |
Why?
|
| Molecular Probes | 1 | 2001 | 27 | 0.050 |
Why?
|
| Fluorescein | 1 | 2001 | 15 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2001 | 124 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2000 | 12 | 0.050 |
Why?
|
| Streptococcus pyogenes | 1 | 2000 | 20 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 2000 | 40 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2001 | 282 | 0.050 |
Why?
|
| Mice, Inbred Strains | 2 | 1991 | 181 | 0.050 |
Why?
|
| G1 Phase | 1 | 2000 | 42 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 807 | 0.050 |
Why?
|
| Virulence | 1 | 2000 | 51 | 0.050 |
Why?
|
| Fetal Heart | 1 | 2000 | 41 | 0.050 |
Why?
|
| Viral Proteins | 1 | 1981 | 150 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 282 | 0.040 |
Why?
|
| Peritoneum | 1 | 2000 | 27 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2000 | 155 | 0.040 |
Why?
|
| Heparin | 2 | 1995 | 205 | 0.040 |
Why?
|
| Mice, Nude | 3 | 2016 | 294 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2019 | 27 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2000 | 189 | 0.040 |
Why?
|
| HIV-1 | 1 | 2001 | 177 | 0.040 |
Why?
|
| Drug Interactions | 1 | 2000 | 289 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 2 | 2013 | 196 | 0.040 |
Why?
|
| Trypsin | 4 | 1989 | 64 | 0.040 |
Why?
|
| Peptides | 3 | 1995 | 455 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1753 | 0.040 |
Why?
|
| Platelet-Derived Growth Factor | 2 | 2006 | 45 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1998 | 107 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 284 | 0.040 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 700 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2002 | 753 | 0.040 |
Why?
|
| Biomarkers | 2 | 2019 | 1593 | 0.040 |
Why?
|
| Tritium | 8 | 1975 | 101 | 0.040 |
Why?
|
| Kidney | 1 | 1983 | 945 | 0.040 |
Why?
|
| Body Patterning | 2 | 2009 | 44 | 0.040 |
Why?
|
| Cell Aggregation | 4 | 1981 | 28 | 0.040 |
Why?
|
| Lymphoma | 1 | 1998 | 116 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2000 | 629 | 0.040 |
Why?
|
| DNA | 2 | 1996 | 597 | 0.040 |
Why?
|
| Melanoma, Experimental | 1 | 1998 | 95 | 0.040 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 1997 | 8 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 246 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 272 | 0.040 |
Why?
|
| Metamorphosis, Biological | 1 | 1976 | 4 | 0.040 |
Why?
|
| Thyroxine | 2 | 1976 | 62 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1997 | 62 | 0.040 |
Why?
|
| Chromatography, Affinity | 2 | 1990 | 73 | 0.030 |
Why?
|
| Osmolar Concentration | 3 | 1996 | 134 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 1996 | 22 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 1996 | 201 | 0.030 |
Why?
|
| Protoporphyrins | 1 | 2016 | 10 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1996 | 134 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1996 | 149 | 0.030 |
Why?
|
| ADAMTS1 Protein | 1 | 2016 | 9 | 0.030 |
Why?
|
| Metalloporphyrins | 1 | 2016 | 25 | 0.030 |
Why?
|
| Keratinocytes | 1 | 1996 | 68 | 0.030 |
Why?
|
| Culture Media | 3 | 1987 | 155 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1998 | 615 | 0.030 |
Why?
|
| Polymers | 2 | 2008 | 244 | 0.030 |
Why?
|
| Peptide Biosynthesis | 1 | 1995 | 5 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 1998 | 300 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1995 | 32 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1995 | 43 | 0.030 |
Why?
|
| Genes, Viral | 1 | 1995 | 44 | 0.030 |
Why?
|
| Gene Library | 1 | 1995 | 68 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1995 | 95 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1995 | 60 | 0.030 |
Why?
|
| beta-Galactosidase | 1 | 1995 | 88 | 0.030 |
Why?
|
| Male | 7 | 2015 | 37321 | 0.030 |
Why?
|
| Necrosis | 1 | 2016 | 239 | 0.030 |
Why?
|
| Aged | 5 | 2015 | 14862 | 0.030 |
Why?
|
| Gene Expression | 2 | 2013 | 770 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 190 | 0.030 |
Why?
|
| Species Specificity | 1 | 1995 | 303 | 0.030 |
Why?
|
| HIV | 1 | 2015 | 56 | 0.030 |
Why?
|
| Monensin | 2 | 1984 | 8 | 0.030 |
Why?
|
| Basement Membrane | 1 | 1974 | 48 | 0.030 |
Why?
|
| Starfish | 1 | 1974 | 1 | 0.030 |
Why?
|
| Cycloheximide | 2 | 1984 | 50 | 0.030 |
Why?
|
| Antibodies | 1 | 1995 | 241 | 0.030 |
Why?
|
| Osteogenesis | 2 | 1974 | 152 | 0.030 |
Why?
|
| Ovum | 1 | 1974 | 24 | 0.030 |
Why?
|
| Adenine | 1 | 1974 | 46 | 0.030 |
Why?
|
| Acetates | 4 | 1985 | 74 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1990 | 79 | 0.030 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 2 | 2006 | 11 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 52 | 0.030 |
Why?
|
| Calcitonin | 1 | 1973 | 21 | 0.030 |
Why?
|
| Growth Hormone | 1 | 1973 | 51 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2013 | 55 | 0.030 |
Why?
|
| Middle Aged | 5 | 2015 | 21147 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 282 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2012 | 93 | 0.030 |
Why?
|
| Cell Count | 2 | 1988 | 248 | 0.030 |
Why?
|
| Capillaries | 1 | 1992 | 105 | 0.030 |
Why?
|
| Mannans | 1 | 2011 | 3 | 0.020 |
Why?
|
| Carbohydrate Sequence | 1 | 2011 | 45 | 0.020 |
Why?
|
| Cerebellar Neoplasms | 1 | 2011 | 17 | 0.020 |
Why?
|
| Fasciitis | 1 | 2011 | 30 | 0.020 |
Why?
|
| Chromatography, DEAE-Cellulose | 2 | 1990 | 14 | 0.020 |
Why?
|
| Aorta | 1 | 1992 | 316 | 0.020 |
Why?
|
| Acetylglucosamine | 1 | 2011 | 46 | 0.020 |
Why?
|
| Cell Physiological Phenomena | 1 | 1990 | 19 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 1991 | 95 | 0.020 |
Why?
|
| Staining and Labeling | 2 | 1985 | 144 | 0.020 |
Why?
|
| Tretinoin | 1 | 1991 | 92 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1033 | 0.020 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2010 | 4 | 0.020 |
Why?
|
| Surface Properties | 2 | 1997 | 363 | 0.020 |
Why?
|
| Virus Latency | 1 | 2010 | 10 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 420 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2010 | 78 | 0.020 |
Why?
|
| Microscopy, Electron | 2 | 1984 | 351 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 1992 | 323 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 326 | 0.020 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 160 | 0.020 |
Why?
|
| Collagen Type X | 1 | 2009 | 1 | 0.020 |
Why?
|
| Binding Sites | 3 | 2002 | 631 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 1 | 2009 | 12 | 0.020 |
Why?
|
| Hedgehog Proteins | 1 | 2009 | 38 | 0.020 |
Why?
|
| Bronchi | 2 | 1999 | 59 | 0.020 |
Why?
|
| Macromolecular Substances | 2 | 1981 | 122 | 0.020 |
Why?
|
| Membranes | 1 | 1988 | 26 | 0.020 |
Why?
|
| Rabbits | 2 | 1987 | 509 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2011 | 219 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 791 | 0.020 |
Why?
|
| Calcium | 2 | 2002 | 929 | 0.020 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 1987 | 41 | 0.020 |
Why?
|
| DNA Replication | 1 | 1988 | 167 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 137 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 1987 | 16 | 0.020 |
Why?
|
| Viscosity | 1 | 1987 | 72 | 0.020 |
Why?
|
| Limb Buds | 1 | 2007 | 8 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2006 | 12 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 2791 | 0.020 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1987 | 138 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2006 | 21 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 62 | 0.020 |
Why?
|
| Hexosamines | 1 | 1966 | 10 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2006 | 6 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2006 | 25 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2006 | 117 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 93 | 0.020 |
Why?
|
| Liposomes | 1 | 1987 | 107 | 0.020 |
Why?
|
| Circular Dichroism | 1 | 2006 | 99 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 320 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 236 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2006 | 114 | 0.020 |
Why?
|
| Acetic Acid | 1 | 1985 | 14 | 0.020 |
Why?
|
| Endometriosis | 1 | 2006 | 56 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2006 | 86 | 0.020 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1987 | 157 | 0.020 |
Why?
|
| Proline | 3 | 2002 | 52 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2006 | 246 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 4848 | 0.020 |
Why?
|
| Rhodamines | 1 | 1985 | 27 | 0.020 |
Why?
|
| Cell Fusion | 1 | 1985 | 23 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2006 | 160 | 0.020 |
Why?
|
| Actins | 1 | 2006 | 249 | 0.020 |
Why?
|
| Binding, Competitive | 2 | 1987 | 165 | 0.020 |
Why?
|
| Tibia | 1 | 1984 | 93 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 317 | 0.010 |
Why?
|
| Bone and Bones | 2 | 1976 | 145 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5717 | 0.010 |
Why?
|
| Deoxycholic Acid | 1 | 1983 | 4 | 0.010 |
Why?
|
| Atherosclerosis | 1 | 2006 | 204 | 0.010 |
Why?
|
| Urodela | 2 | 1975 | 31 | 0.010 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 318 | 0.010 |
Why?
|
| Lung | 2 | 1998 | 849 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 48 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1982 | 62 | 0.010 |
Why?
|
| Chemistry | 1 | 1982 | 45 | 0.010 |
Why?
|
| Streptomyces | 1 | 1982 | 15 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2004 | 258 | 0.010 |
Why?
|
| Glutaral | 1 | 1982 | 41 | 0.010 |
Why?
|
| Acetylglucosaminidase | 1 | 1982 | 8 | 0.010 |
Why?
|
| Glucuronidase | 1 | 1982 | 11 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 28 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 2002 | 20 | 0.010 |
Why?
|
| Chemotaxis | 1 | 2002 | 38 | 0.010 |
Why?
|
| Glucosamine | 1 | 1982 | 8 | 0.010 |
Why?
|
| Gelatin | 1 | 2002 | 14 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1982 | 23 | 0.010 |
Why?
|
| Vitreous Body | 1 | 1982 | 26 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 112 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 80 | 0.010 |
Why?
|
| Glycine | 1 | 2002 | 89 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1982 | 137 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2002 | 121 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1971 | 54 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 258 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1980 | 618 | 0.010 |
Why?
|
| Matrix Metalloproteinase 15 | 1 | 2000 | 5 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1981 | 136 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 376 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 778 | 0.010 |
Why?
|
| Adenofibroma | 1 | 1999 | 1 | 0.010 |
Why?
|
| Mutation | 2 | 2002 | 1213 | 0.010 |
Why?
|
| Mouth Mucosa | 1 | 2000 | 51 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1980 | 167 | 0.010 |
Why?
|
| Contrast Media | 1 | 2003 | 595 | 0.010 |
Why?
|
| Carbohydrates | 1 | 1979 | 57 | 0.010 |
Why?
|
| Glucose | 2 | 1971 | 307 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2006 | 3187 | 0.010 |
Why?
|
| Codon, Initiator | 1 | 1998 | 1 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 659 | 0.010 |
Why?
|
| 5' Untranslated Regions | 1 | 1998 | 16 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 1998 | 134 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 1997 | 4 | 0.010 |
Why?
|
| Tumor Escape | 1 | 1997 | 37 | 0.010 |
Why?
|
| Triturus | 1 | 1977 | 1 | 0.010 |
Why?
|
| Ambystoma | 1 | 1977 | 33 | 0.010 |
Why?
|
| Rana catesbeiana | 1 | 1976 | 5 | 0.010 |
Why?
|
| Cricetulus | 1 | 1997 | 98 | 0.010 |
Why?
|
| Larva | 1 | 1976 | 39 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1977 | 128 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1977 | 186 | 0.010 |
Why?
|
| Salamandridae | 1 | 1975 | 1 | 0.010 |
Why?
|
| Culture Techniques | 2 | 1973 | 65 | 0.010 |
Why?
|
| Chromatography | 3 | 1973 | 47 | 0.010 |
Why?
|
| Lanthanum | 1 | 1974 | 3 | 0.010 |
Why?
|
| Chickens | 2 | 1974 | 232 | 0.010 |
Why?
|
| Ruthenium | 1 | 1974 | 5 | 0.010 |
Why?
|
| Meiosis | 1 | 1974 | 5 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1974 | 34 | 0.010 |
Why?
|
| Methane | 1 | 1974 | 16 | 0.010 |
Why?
|
| Endothelium | 1 | 1974 | 98 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 2223 | 0.010 |
Why?
|
| Hindlimb | 1 | 1972 | 38 | 0.010 |
Why?
|
| Comb and Wattles | 1 | 1972 | 2 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1972 | 29 | 0.010 |
Why?
|
| Cyclic AMP | 1 | 1973 | 223 | 0.010 |
Why?
|
| Thymidine | 1 | 1972 | 32 | 0.010 |
Why?
|
| Umbilical Cord | 1 | 1972 | 19 | 0.010 |
Why?
|
| Ascorbic Acid | 1 | 1972 | 45 | 0.010 |
Why?
|
| Sodium Isotopes | 1 | 1971 | 1 | 0.010 |
Why?
|
| Chromatography, Thin Layer | 1 | 1971 | 52 | 0.010 |
Why?
|
| Autoradiography | 1 | 1971 | 94 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 8912 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1987 | 82 | 0.000 |
Why?
|
| Temperature | 1 | 1981 | 341 | 0.000 |
Why?
|
| Micropore Filters | 1 | 1978 | 5 | 0.000 |
Why?
|
| Egtazic Acid | 1 | 1978 | 29 | 0.000 |
Why?
|
| Gels | 1 | 1978 | 55 | 0.000 |
Why?
|
| Serum Albumin, Bovine | 1 | 1978 | 43 | 0.000 |
Why?
|
| Fetal Blood | 1 | 1978 | 131 | 0.000 |
Why?
|
| Forelimb | 1 | 1975 | 15 | 0.000 |
Why?
|
| Denervation | 1 | 1975 | 23 | 0.000 |
Why?
|
| Bone Regeneration | 1 | 1975 | 20 | 0.000 |
Why?
|
| Nerve Regeneration | 1 | 1975 | 42 | 0.000 |
Why?
|
| Methylcellulose | 1 | 1973 | 6 | 0.000 |
Why?
|
| Autoanalysis | 1 | 1973 | 11 | 0.000 |
Why?
|
| Hydroxyproline | 1 | 1973 | 33 | 0.000 |
Why?
|
| Brain Chemistry | 1 | 1974 | 173 | 0.000 |
Why?
|
| Lysine | 1 | 1973 | 96 | 0.000 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1973 | 73 | 0.000 |
Why?
|